Cullinan Therapeutics, Inc. ( CGEM) - Key Metrics
CGEM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.86 | -$0.64 | -$0.64 |
| 2025Q3 | ? | -$0.86 | -$0.62 | ? |
| 2025Q2 | ? | -$1.19 | -$0.98 | -$0.98 |
| 2025Q1 | ? | -$0.82 | -$0.73 | -$0.73 |
CGEM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.02 |
| 2025Q3 | ? | -1.73 |
| 2025Q2 | ? | -1.59 |
| 2025Q1 | ? | -2.30 |
CGEM
Price: $13.61
52 week price:
Earnings Per Share: -3.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 351200
Market Capitalization: 850.3 million